Newsletter | June 2, 2026

06.02.26 -- Why the Right Manufacturing Partner Is About More Than Capacity

FOCUS ON MANUFACTURING

Why the Right Manufacturing Partner Is About More Than Capacity

In this Cell & Gene Live, experts Emily Moran, Founder, 3LB Consulting, LLC, and Sugu Patro, Ph.D., Senior Vice President Global Process Development at Kite, a Gilead Company, explored what truly defines a successful manufacturing partnership in CGT by emphasizing that technical fit, regulatory strength, process understanding, and long-term strategic alignment matter more than price or available capacity alone.

Fluid Management In HPAPI Manufacturing

Protect operators and simplify Annex 1 alignment. Discover how closed-system approaches cut labor by 90% while ensuring complete containment in hazardous drug production.

Supporting The Future Of cGMP Drug Product Manufacturing

Accelerate your operational readiness. Holistic training and validation services help manufacturers navigate modern regulatory frameworks and master complex bioprocesses.

2026 Manufacturing Trends Reshaping Life Sciences

Explore the manufacturing trends shaping 2026, from AI in validated environments to connected systems and digital workforce readiness that are building more agile, resilient, and compliant operations.

Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies

Boost viral yields across serotypes. Learn how a streamlined approach to transient AAV production optimizes transfection parameters for scalable, predictable workflows.

The Ultimate Guide To Stress-Free Pipetting

Improve accuracy and reduce stress with expert pipetting tips. Gain insight into how technique and tool selection can boost precision and efficiency, ensuring consistent results across every lab workflow.

A Novel Transfection System For Cell And Gene Therapy Applications

An innovative transfection system addresses common production challenges by offering higher AAV titers, improved percent-full AAV capsids, and a straightforward workflow for AAV production platforms.

Using Next Generation Sequencing Methods For Virus Vector Identity Testing

Sequencing techniques play a crucial role in establishing the quality attributes of a variety of therapeutic products. Uncover the advantages NGS offers for obtaining accurate sequences.

A Case Study For Viral Vector Process Impurity Profile: Evaluation Of EndoCleave

Maximize host cell DNA clearance. Review performance data comparing a new endonuclease option against standard industry enzymes in both AAV and LVV production lines.

Optimize, Automate, And Scale Closed-System MSC Expansion

Efficiently scale your MSC therapy manufacturing with closed systems. Read how a dual-component media kit streamlines automation, reduces variability, and ensures seamless scale-up with minimal optimization.

Practical Strategy To Single-Use Filtration In Biopharma

In the evolving world of biopharmaceutical manufacturing, understand how single-use filtration remains a vital yet overlooked process essential to ensuring product purity and patient safety.

MANUFACTURING SOLUTIONS

Gene Therapy Applications Guide - Danaher Life Sciences

A Pilot-Scale, Sedimenting Centrifuge - CARR Biosystems

Exosomes/Extracellular Vesicles - RoosterBio

RNA Polymerase Engineered For Safety And Cost-Effectivity - Aldevron

A Scaled-Down Solution For Simple, Robust Upstream Intensification - Repligen

Connect With Cell & Gene: